Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GlaxoSmithKline New Year’s Resolutions Include Uping Commit Promotions

This article was originally published in The Tan Sheet

Executive Summary

A clinical study bolstering GlaxoSmithKline's campaign for Commit polacrilex lozenge, which targets smokers who have already tried other forms of nicotine replacement therapy, was released by the firm Jan. 2

You may also be interested in...

Glaxo NRT Promotional Campaign Targets Smokers Not Ready To Quit

GlaxoSmithKline is launching a $20 mil. ad campaign to boost the firm's lagging smoking cessation product sales following a disappointing second quarter performance

Nicotine Lozenge Underdosing Discouraged In GSK Smoking Cessation Study

Smokers should be encouraged to use at least seven to eight nicotine lozenges per day when attempting to quit smoking, researchers suggest in the June 10 Archives of Internal Medicine

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts